Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTRIPS
ChiCTR-IPR-15005990Phase 4Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Mar 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Sjögren syndrome-associated interstitial lung disease (SS-ILD) comparing glucocorticoid + cyclosporine with glucocorticoid + placebo (2 arms). Primary endpoint: Forced vital capacity (FVC). Planned start Mar 2015; status: not yet recruiting.
02
Drugs
cyclosporine
03
Conditions
Sjögren syndrome-associated interstitial lung disease (SS-ILD)
Beyond the preview
Go deeper on ChiCTR-IPR-15005990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15005990.